Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

14.45p
   
  • Change Today:
      0.43p
  • 52 Week High: 28.00
  • 52 Week Low: 7.05
  • Currency: UK Pounds
  • Shares Issued: 155.12m
  • Volume: 7,000
  • Market Cap: 22.41m
  • RiskGrade: 364

Immupharma Overview

Immupharma is in the pharma and biotech sector and is currently trading at 14.45p per share. In the last year Immupharma's share price has ranged from 7.05p to 28.00p and brokers are currently rating this stock as 'strong sell'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -7850.0% -5100.0%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 271.9 212.1
Pr/Book 4.1  
Latest F'cast
Revenue n/a 25.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Immupharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-15 0.08 (4.55) (4.40)p n/a n/a n/a n/a 0.0%
31-Dec-16 0.16 (6.31) (4.54)p n/a n/a n/a n/a 0.0%
31-Dec-17 0.15 (7.00) (4.75)p n/a n/a n/a n/a 0.0%
31-Dec-18 0.08 (7.96) (5.19)p n/a n/a n/a n/a 0.0%
31-Dec-19 0.08 (6.74) (3.99)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Immupharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 0.10 (5.10) (2.80)p n/a n/a n/a n/a 0.0%
31-Dec-21 0.10 (5.40) (2.90)p n/a n/a n/a n/a 0.0%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

Immupharma Company Announcements

FDA submission for Special Protocol Assessment 27-Jul-2020 07:00 RNS
2020 AGM – ALL RESOLUTIONS PASSED 18-Jun-2020 11:31 RNS
Total Share Capital Notification 16-Jun-2020 07:00 RNS

Latest Immupharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Immupharma Market Data

Currency UK Pounds
Share Price 14.45p
Change Today 0.43p
% Change 3.03 %
52 Week High 28.00
52 Week Low 7.05
Volume 7,000
Shares Issued 155.12m
Market Cap 22.41m
RiskGrade 364

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
61.68% below the market average61.68% below the market average61.68% below the market average61.68% below the market average61.68% below the market average
17.86% above the sector average17.86% above the sector average17.86% above the sector average17.86% above the sector average17.86% above the sector average
Price Trend
48.17% above the market average48.17% above the market average48.17% above the market average48.17% above the market average48.17% above the market average
5.26% above the sector average5.26% above the sector average5.26% above the sector average5.26% above the sector average5.26% above the sector average
Income Not Available
Growth
42.93% below the market average42.93% below the market average42.93% below the market average42.93% below the market average42.93% below the market average
65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 0
Sell 0
Strong Sell 1
Total 1
strong_sell
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Immupharma Dividends

No dividends found

Trades for 05-Aug-2020

Time Volume / Share Price
08:06 5,000 @ 14.45p
08:05 2,000 @ 14.05p

Immupharma Key Personnel

CEO Dimitri Dimitriou

Top of Page